Literature DB >> 27275097

Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity.

Frederik Trier Moller1, Lina Knudsen1, Marcus Harbord1, Jack Satsangi1, Hannah Gordon1, Lene Christiansen1, Kaare Christensen1, Tine Jess1, Vibeke Andersen1.   

Abstract

AIM: To describe the establishment of a Danish inflammatory bowel diseases (IBD) twin cohort with focus on concordance of treatment and inflammatory markers.
METHODS: We identified MZ twins, likely to be discordant or concordant for IBD, by merging information from the Danish Twin Register and the National Patient Register. The twins were asked to provide biological samples, questionnaires, and data access to patient files and public registries. Biological samples were collected via a mobile laboratory, which allowed for immediate centrifugation, fractionation, and storage of samples. The mean time from collection of samples to storage in the -80 °C mobile freezer was less than one hour. The diagnoses where validated using the Copenhagen diagnostic criteria.
RESULTS: We identified 159 MZ IBD twin pairs, in a total of 62 (39%) pairs both twins agreed to participate. Of the supposed 62 IBD pairs, the IBD diagnosis could be confirmed in 54 pairs. The cohort included 10 concordant pairs, whereof some were discordant for either treatment or surgery. The 10 concordant pairs, where both pairs suffered from IBD, included eight CD/CD pairs, one UC/UC pair and one UC/IBDU pair. The discordant pairs comprised 31 UC, 5 IBDU (IBD unclassified), and 8 CD discordant pairs. In the co-twins not affected by IBD, calprotectin was above 100 μg/g in 2 participants, and above 50 μg/g in a further 5 participants.
CONCLUSION: The presented IBD twin cohorts are an excellent resource for bioinformatics studies with proper adjustment for disease-associated exposures including medication and inflammatory activity in the co-twins.

Entities:  

Keywords:  Biobank; Crohn’s disease; Digestive system diseases; Epidemiologic studies; Inflammatory bowel diseases; Twins; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 27275097      PMCID: PMC4886380          DOI: 10.3748/wjg.v22.i21.5050

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Genetics in twins with Crohn's disease: less pronounced than previously believed?

Authors:  Jonas Halfvarson
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

Review 2.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

3.  Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system.

Authors:  K Fonager; H T Sørensen; S N Rasmussen; J Møller-Petersen; M Vyberg
Journal:  Scand J Gastroenterol       Date:  1996-02       Impact factor: 2.423

Review 4.  The continuing value of twin studies in the omics era.

Authors:  Jenny van Dongen; P Eline Slagboom; Harmen H M Draisma; Nicholas G Martin; Dorret I Boomsma
Journal:  Nat Rev Genet       Date:  2012-07-31       Impact factor: 53.242

5.  CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.

Authors:  J Halfvarson; F Bresso; M D'Amato; G Järnerot; S Pettersson; C Tysk
Journal:  Dig Liver Dis       Date:  2005-10       Impact factor: 4.088

6.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

7.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

8.  Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.

Authors:  Tine Jess; Jacob Simonsen; Nete Munk Nielsen; Kristian Tore Jørgensen; Peter Bager; Steen Ethelberg; Morten Frisch
Journal:  Gut       Date:  2010-12-29       Impact factor: 23.059

9.  Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Authors:  Ben Willing; Jonas Halfvarson; Johan Dicksved; Magnus Rosenquist; Gunnar Järnerot; Lars Engstrand; Curt Tysk; Janet K Jansson
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  2 in total

1.  Identification of Disease-associated Traits and Clonotypes in the T Cell Receptor Repertoire of Monozygotic Twins Affected by Inflammatory Bowel Diseases.

Authors:  Elisa Rosati; Mikhail V Pogorelyy; C Marie Dowds; Frederik T Moller; Signe B Sorensen; Yuri B Lebedev; Norbert Frey; Stefan Schreiber; Martina E Spehlmann; Vibeke Andersen; Ilgar Z Mamedov; Andre Franke
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

2.  Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases.

Authors:  Katja A Selin; Charlotte R H Hedin; Eduardo J Villablanca
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.